This once-weekly subcutaneous injectable drug, which mimics the natural GLP-1 hormone and activates GLP-1 receptors in the gastrointestinal tract, pancreas, and brain in response to food, 7 was initially used solely for diabetes treatment
What questions about BPC-157 safety still need answering
Journal reference: Using large language models to assess public perceptions around glucagon-like peptide-1 receptor agonists on social media
Dig deeper: The good news is he says it is usually temporary
Neumann J, Boknik P, Matherne GP, Lankford A, Schmitz W (2003) Pertussis toxin sensitive and insensitive effects of adenosine and carbachol in murine atria overexpressing A(1)-adenosine receptors
Maya Bunik, a Colorado pediatrician and chair of the American Academy of Pediatrics section on breastfeeding, in her book about the practice